$16.780
-0.800 (-4.77%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BCAX Prediction & Forecast by Similar Chart Analysis
Alphio's BCAX stock price prediction model matches the current Bicara Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.80 (+0.09%). The 1-week path is $16.86 (+0.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bicara Therapeutics Inc Stock?
Bicara Therapeutics Inc is currently not a strong buy due to its recent performance and financial losses, despite a potential upside reflected in analyst price targets. The current price is $17.50, with a forward P/E of 0, indicating no earnings expected in the near term. The RSI is at 38.166, suggesting the stock is nearing oversold territory, but the company reported a net loss of $56.2 million in Q1 2026, which raises concerns about its financial health. While analysts have set price targets as high as $39, the significant losses and management changes create uncertainty, warranting a hold recommendation for now.
BCAX stock price ended at $16.78 on Friday, after losing -4.77%
Bicara Therapeutics Inc (BCAX) last closed at $16.78, losing -4.77%. These facts feed the 1-day and 1-week BCAX price prediction above.
Forecast Drivers
Bicara Therapeutics Inc (BCAX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BCAX, ranked by similarity.
Seasonality analysis for BCAX
Historically the probability of a positive October return for BCAX is 58.62%. September offers the highest probability of a positive month at 59.26%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BCAX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $10.67 | $11.92 | $14.31 | -28.96% |
| Nov 2026 | $7.57 | $9.92 | $10.55 | -40.91% |
| Dec 2026 | $10.44 | $12.80 | $14.55 | -23.72% |
In 2026, Bicara Therapeutics Inc (BCAX) is projected to range from $7.57 to $14.55.
Bicara Therapeutics Inc 2026 monthly forecast
In Oct 2026, Bicara Therapeutics Inc is projected to average $11.92, with a low of $10.67 and high of $14.31.
In Nov 2026, Bicara Therapeutics Inc is projected to average $9.92, with a low of $7.57 and high of $10.55.
In Dec 2026, Bicara Therapeutics Inc is projected to average $12.80, with a low of $10.44 and high of $14.55.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.